| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/09/2003 | CA2480664A1 Cancer associated protein phosphatases and their uses |
| 10/09/2003 | CA2480633A1 Neurotrophic and neuroprotective peptides |
| 10/09/2003 | CA2480554A1 Bone generation by gene therapy |
| 10/09/2003 | CA2480494A1 Synthetic active peptide fragments |
| 10/09/2003 | CA2480419A1 Antiopoietin-related growth factor |
| 10/09/2003 | CA2480382A1 Hbv drug resistance drug resistance detection methods |
| 10/09/2003 | CA2480319A1 Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 10/09/2003 | CA2480277A1 Ehanced protein expression in bacillus |
| 10/09/2003 | CA2480157A1 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures |
| 10/09/2003 | CA2480128A1 Methods of using flt3-ligand in immunization protocols |
| 10/09/2003 | CA2479763A1 Potent oncolytic herpes simplex virus for cancer therapy |
| 10/09/2003 | CA2479750A1 Fibrinogen binding moieties |
| 10/09/2003 | CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 10/09/2003 | CA2477268A1 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine |
| 10/09/2003 | CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/08/2003 | EP1350850A2 Method for expressing foreign genes and vectors therefor |
| 10/08/2003 | EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof |
| 10/08/2003 | EP1350847A1 Human glioma antigen and process for preparing the same |
| 10/08/2003 | EP1350840A1 Adaptation sites of PRRSV |
| 10/08/2003 | EP1350839A1 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti |
| 10/08/2003 | EP1350838A1 Expression of recombinant human proteins in Tetrahymena |
| 10/08/2003 | EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor |
| 10/08/2003 | EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays |
| 10/08/2003 | EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays |
| 10/08/2003 | EP1350796A1 Attenuated gram negative bacteria |
| 10/08/2003 | EP1350795A1 Method of constructing three-dimensional structure of transmembrane protein |
| 10/08/2003 | EP1350525A2 Matrix-free osteogenic devices, implants and methods thereof |
| 10/08/2003 | EP1350521A1 Immunotherapeutic combinations for the treatment of tumors |
| 10/08/2003 | EP1350114A2 Detection of survivin in the biological fluids of cancer patients |
| 10/08/2003 | EP1350113A2 Inhibition of cmv infection and dissemination |
| 10/08/2003 | EP1350109A1 Marker for inflammatory conditions |
| 10/08/2003 | EP1350105A2 Immunoassays for anti-hcv antibodies |
| 10/08/2003 | EP1350104A2 Presenilin enhancers |
| 10/08/2003 | EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 10/08/2003 | EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 10/08/2003 | EP1349955A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 10/08/2003 | EP1349945A2 Method for the production of a heterologous protein by a fungus |
| 10/08/2003 | EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 10/08/2003 | EP1349937A2 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains |
| 10/08/2003 | EP1349936A2 Regulation of human b7-h2 protein |
| 10/08/2003 | EP1349935A2 Molecules for disease detection and treatment |
| 10/08/2003 | EP1349934A2 Compositions and methods relating to breast specific genes and proteins |
| 10/08/2003 | EP1349933A2 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 10/08/2003 | EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same |
| 10/08/2003 | EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/08/2003 | EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 10/08/2003 | EP1349929A2 Apoptosis-inducing dna sequences |
| 10/08/2003 | EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof |
| 10/08/2003 | EP1349925A2 Functional balanced-lethal host-vector systems |
| 10/08/2003 | EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 10/08/2003 | EP1349922A2 Regulation of target protein activity through modified proteins |
| 10/08/2003 | EP1349874A2 Peptide and polypeptide inhibitors of complement c1s |
| 10/08/2003 | EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses |
| 10/08/2003 | EP1349872A2 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 10/08/2003 | EP1349871A2 Novel marker for the diagnosis and therapy of tumours |
| 10/08/2003 | EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 10/08/2003 | EP1349869A1 Method of identifying antibacterial compounds |
| 10/08/2003 | EP1349868A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 10/08/2003 | EP1349867A2 Dimeric fluorescent polypeptides |
| 10/08/2003 | EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 10/08/2003 | EP1349573A1 Collectins as adjuvants |
| 10/08/2003 | EP1349571A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 10/08/2003 | EP1349570A1 ENTEROHEMORRAGIC i ESCHERICHIA COLI /i VACCINE |
| 10/08/2003 | EP1349569A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 10/08/2003 | EP1349568A1 Immunomodulatory constructs and their uses |
| 10/08/2003 | EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 10/08/2003 | EP1349564A2 Regulation of cellproliferation and differentiation using topically applied peptides |
| 10/08/2003 | EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 10/08/2003 | EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 10/08/2003 | EP1349445A2 Senescence-associated plant promotors |
| 10/08/2003 | EP1100530B1 In-vitro stimulation of beta cell proliferation |
| 10/08/2003 | EP1045918A4 G protein-related kinase mutants in essential hypertension |
| 10/08/2003 | EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 10/08/2003 | EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same |
| 10/08/2003 | EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2 |
| 10/08/2003 | EP0819010B1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous sucrose solution |
| 10/08/2003 | EP0750628B1 Fibroblast growth factor-10 |
| 10/08/2003 | EP0670898B1 Interleukin-3 (il-3) mutant polypeptides |
| 10/08/2003 | EP0650364B1 Purification of factor ix |
| 10/08/2003 | EP0607392B1 Plasma fraction purification |
| 10/08/2003 | EP0566647B1 Improved humanized immunoglobulins |
| 10/08/2003 | EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
| 10/08/2003 | CN1447920A Compsns. and methods for modulating tumor specific expression |
| 10/08/2003 | CN1447919A Use of antibodies against specific MHC-Peptide complexes |
| 10/08/2003 | CN1447862A Method for determining three-D protein structure from primary protein sequence |
| 10/08/2003 | CN1447859A Isozymes of lacrimator component synthase and gene encoding same |
| 10/08/2003 | CN1447858A Complex |
| 10/08/2003 | CN1447856A Nucleic acid sequences and methods for modification of plant gene expression |
| 10/08/2003 | CN1447819A Human CYR 61 |
| 10/08/2003 | CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 10/08/2003 | CN1446915A Recombinant sweet protein suitable for expressed in filamentous fungus and its production methods |
| 10/08/2003 | CN1446913A Technique method for preparing hydratase of carbonitrile mitrile by using glucose-CO2+ coupling adding ferment |
| 10/08/2003 | CN1446825A Synthetic chimeric peptide of human chorionic gonadotrophin genetic engineering and its preparation method |
| 10/08/2003 | CN1446824A Vasoconstriction factor and preparation method as well as its application in pharmacy |
| 10/08/2003 | CN1446823A Overreationg factor as well as its preparation factor and gene |
| 10/08/2003 | CN1446822A Acidic antibacterial peptides and gene as well as its application in pharmacy |
| 10/08/2003 | CN1123639C Human activated protein C and its prepn. process |
| 10/08/2003 | CN1123574C Ligands for FLT3 receptors |
| 10/07/2003 | USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance |
| 10/07/2003 | US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests |